At the IPA summit, pharma leaders said India's 2047 ambitions depend on embedding AI, strengthening trust and accelerating ...

Artificial intelligence is quietly reshaping the pharmaceutical industry and the financial upside could be enormous.

Drug development is notoriously failure-prone. Only one in every ten drug candidates that enter human trials eventually goes onto the market. Turning a promising molecule into a useful medicine ...

Pharma first started using artificial intelligence in the clinical and development space, but over the last two years, the industry has expanded its use, according to Sandy Donaldson, cofounder ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Biotech firms use AI in trials to target patients more ...

A closer look at how robotics is reshaping pharmaceutical manufacturing, from improving quality and compliance to enabling more scalable production, and where the technology is headed next.

For commercial leaders, this environment challenges longstanding assumptions about pricing strategy, geographic prioritization, and commercial engagement. Three imperatives now face leaders seeking ...

For two decades, the branded pharma website has been treated as the centerpiece of digital engagement. It has been the polished ‘front door’, where brands prepared to tell their story and hoped ...

AI has impacted the work of healthcare professionals (HCPs) in various ways, leading to some significant behavioral shifts. In December 2025, my company released a report featuring insights from ...

India’s pharmaceutical industry is entering a defining phase of expansion that is reshaping how the sector operates, supported by stronger domestic capabilities, deeper scientific focus, wider therapy ...